MetaCap

Artivion (AORT) vs iRadimed (IRMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

iRadimed (IRMD) has outperformed Artivion (AORT) over the past year, losing 9.5% versus a loss of 59.8%. Over five years, IRMD leads with a +91.6% price change compared with -0.8% for AORT. iRadimed is the larger company by market cap ($1.04 billion vs $886.0 million), about 1.2 times the size.

On valuation, iRadimed trades at a lower forward P/E (33.3x vs 34.9x for Artivion). iRadimed pays a dividend yielding 0.99%, while Artivion does not currently pay one. iRadimed converts more of its revenue into profit, with a net margin of 26.8% versus 2.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AORT-59.76%IRMD-9.50%
+21%-21%-64%
Nov 21, 20251 yearNov 20, 2026
AORT-4.17%IRMD+107.53%
+176%+59%-58%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AORT versus IRMD key metrics
MetricAORTIRMD
Share price$18.16$81.02
Market cap$886.02M$1.04B
1-day change-2.00%-0.30%
YTD return-60.18%-16.71%
1-year return-59.76%-9.50%
5-year return-0.82%+91.58%
P/E ratio (TTM)—43.33
Forward P/E34.9233.25
EPS (TTM)$-0.36$1.87
Dividend yield0.00%0.99%
Annual dividend$0.00$0.80
Revenue (latest FY)$441.33M$83.81M
Revenue growth (YoY)+13.59%+14.43%
Net income (latest FY)$9.77M$22.48M
Gross margin64.40%76.75%
Operating margin7.65%31.20%
Net margin2.21%26.82%
52-week high$48.25$107.90
52-week low$18.12$76.35
Distance from 52-week high-62.36%-24.91%
Analyst consensusstrong_buynone
Avg. price target upside+111.84%+45.64%
Average volume671.97K120.89K
Shares outstanding48.79M12.79M
Employees1,800166
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • IRMD has outperformed AORT by 50.3 percentage points over the past year.
  • iRadimed is more profitable, keeping 26.8 cents of every revenue dollar as net income versus 2.2 cents for Artivion.

About Artivion

AORT stock →

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Health Care · Medical/Dental Instruments · 1,800 employees

About iRadimed

IRMD stock →

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.

Health Care · Medical/Dental Instruments · 166 employees

AORT vs IRMD FAQ

Which is bigger, Artivion or iRadimed?

iRadimed (IRMD) is larger, with a market capitalization of $1.04B compared with $886.02M for Artivion (AORT).

Which stock has performed better over the past year, AORT or IRMD?

IRMD returned -9.50% over the past 12 months, compared with -59.76% for AORT (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Artivion or iRadimed?

iRadimed pays a dividend yielding 0.99%, while Artivion does not currently pay a regular dividend.

Are Artivion and iRadimed in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons